Therefore, while the specific role of CCL24 in HL has not been mentioned, the broader understanding of its potential as a biomarker in various cancers and its associations with disease progression and prognosis suggest that it could be a valuable area of investigation for HL as well. This evidence concerns the gene CCL24 and Hodgkins lymphoma.